GNTA

Conviction 53HealthcareScan · Thu, Jun 25, 2026

GNTA$1.75-5.68%

ResistanceSupportVol 14

Vol MA14 463.69K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Genenta Science S.p.A.Biotechnologywww.genenta.com ↗

Price1.75

Change-5.68%

Gap-0.54%

Rel volume0.17×

Avg volume4.06M

Avg $ vol6.89M

SMA 201.76

SMA 501.11

SMA 2001.62

Price vs 50+57.43%

Price vs 200+7.93%

MA stackmixed

50/200 cross—

Supertrendup · 1.15

RSI (14)57

MACD hist-0.04

MACD crossbear · 4d

Stoch %K / %D46 / 50

ADX (14)36

+DI / −DI25 / 14

RSI divergence—

MACD divergence—

ATR %+13.91%

ADR %17.96%

52w high6.20

52w low0.5800

From 52w high-71.85%

Above 52w low+200.86%

New 52w highNo

SqueezeOff

Bollinger width69.38%

%B0.48

Donchian pos54.42%

Donchian high2.58

Donchian low0.7479

AVWAP (52w high)2.34

vs AVWAP high-25.55%

AVWAP (52w low)1.71

vs AVWAP low+1.86%

OBV trendUp

Chaikin MF (20)-0.40

Today vs 20d0.17×

Avg vol (14d)463.69K

Avg vol (20d)4.06M

Avg $ vol (20d)6.89M

Market cap40.89M

RS 3m (vs SPY)+144.69%

RS 6m (vs SPY)+19.85%

RS line new highNo

Trend template4/8

Technical rank76.7

1 week-5.16%

1 month+192.10%

3 months+132.57%

6 months+18.71%

1 year-43.34%

YTD+23.76%

P/E—

P/B—

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current—

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target—

Target upside—

Analyst rating—

Institutional5.35%

Ent. value15.19M

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeNasdaq

Shares out23.59M

Employees9

ListedWed, Dec 15, 2021

Free float13.87M

Float %58.8%

Short interest315.88K

Days to cover0.3d

Short volume33.2%

Squeeze score6 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction53 / 100

Pattern quality—

Tech rank76.7 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance2.31

Support0.5500

Days since event—

Candle confirm—

News sentiment—

Congress activity

Disclosed STOCK Act trades in GNTA

All disclosures →

No recent disclosed trades by Congress in GNTA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in GNTA · 1 buy

Insider	Side	Shares	Value	Traded	Filed
Paracchi Pierluigi Chief Executive Officer · Stock Option (right to buy) · 2026-03-30	Grant	100K	$0	2026-03-30	2026-05-05

SEC filings

EDGAR filings in GNTA · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.